Dr. Randall Rosenblatt

Yolanda Mageto, MD, MPH, a pulmonary critical care specialist with nationally recognized expertise in interstitial lung disease (ILD), has assumed the role of Medical Director of Interstitial Lung Disease at Baylor University Medical Center at Dallas. Dr. Mageto attended medical school at Washington University in St. Louis, Missouri and completed her residency and training at University of Texas Southwestern and her fellowship in pulmonary and critical care medicine at the University of Washington in Seattle with a focus in ILD. Since that time she has held faculty positions at the University of Washington Seattle, University of Texas Southwestern and most recently University of Vermont where she rose to the rank of full Professor. Dr. Mageto is a clinician, educator and researcher involved in multiple idiopathic pulmonary fibrosis/ILD trials over last 20 years including collaborations with investigators from other centers in sarcoidosis related lung disease. She remains actively involved in the total care and management of her patients. Dr. Mageto is dedicated to the development of a Comprehensive Integrated Interstitial Lung disease program optimizing delivery of care to patients with interstitial lung disease in the Dallas Fort Worth Area. In her spare time she enjoys spending time with her family, travelling, reading a good book and cooking. Dr. Mageto is highly rated in 12 conditions, according to our data. Her top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, and Hypersensitivity Pneumonitis.

"Dr. Rahimi is board certified in transplant hepatatology, gastroenterology and internal medicine. His clinical interests include chronic liver disease, liver cancer, liver failure, metabolic and autoimmune diseases of the liver, viral hepatitis, complications of cirrhosis and liver transplantation. Dr. Rahimi has authored several research articles on improving the outcomes of patients with advanced liver disease. Dr. Rahimi holds a Master of Science in Applied Physiology from Finch University of Health Sciences in North Chicago and medical degree from Chicago Medical School. While completing his internship and residency in Internal Medicine at the University of Virginia in Charlottesville, VA, he concurrently obtained a Master of Science in Clinical Research in the Department of Public Health. Upon relocating to Dallas, Dr. Rahimi completed two fellowships, the first in Gastroenterology at the University of Texas Southwestern Medical Center followed by a fellowship in Transplant Hepatology at Baylor University Medical Center, part of Baylor Scott & White Health, in Dallas. Read more about Dr. Rahimi’s publications on PubMed.gov and the Baylor Health Sciences Library . Read Dr. Rahimi's article, ""5 things you need to know about fatty liver disease (and how to reverse it)"" . Dr. Rahimi is involved in a study around the use of statins in patients with advanced liver failure and cirrhosis. Read more here . Dr. Rahimi was recognized by D Magazine as a Best Doctor for 2024 and 2025. Read Dr. Rahimi's article, ""Can fatty liver be reversed? 5 common questions, answered.""". Dr. Rahimi is highly rated in 11 conditions, according to our data. His top areas of expertise are Liver Failure, Esophageal Varices, Ascites, Liver Transplant, and Hepato-Pancreato-Biliary Surgery.

Sumeet Asrani, MD, MSc is the Chief of Hepatology and Liver Transplantation at the Baylor Simmons Transplant Institute in Dallas. He has served as the Medical Director of the Center for Advanced Liver Disease since 2016. He provides clinical care at Baylor University Medical Center (BUMC) and Baylor Scott and White Medical Center – Waxahachie. Recently, Dr. Asrani has restructured the research enterprise of the Simmons Transplant Institute and has been instrumental in elevating the name of the Institute and Baylor Scott & White as a recognized presence in the national and international academic world. Dr. Asrani received his medical degree from Baylor College of Medicine in Houston. He did his internship and residency at Washington University School of Medicine in St. Louis, MO. He went on to complete fellowships in gastroenterology, hepatology and transplant hepatology at the Mayo Clinic in Rochester, Minnesota before joining the transplant hepatology team at Baylor University Medical Center in 2013. Dr. Asrani has published 140 peer review publications, 300 abstracts and given over 125 national and international presentations. In addition, he has mentored more than 30 trainees to help advance their medical careers. Dr. Asrani previously served as an associate editor for the American Journal of Transplantation (AJT) and as an associate editor for Liver Transplantation (LT). He is actively involved in national and international collaborations to improve care for patients with liver disease. Dr. Asrani specializes in the management of patients with end-stage liver disease, liver transplantation candidates and recipients. His other clinical interests include liver cancer, viral hepatitis, autoimmune hepatitis, primary sclerosing cholangitis and alcohol associated liver disease. His research interests focus on early identification of patients with cirrhosis, improving quality of patients with liver disease especially in the rural setting, improving kidney function in patients with liver disease and organ allocation. In his free time, Dr, Asrani enjoys various fitness endeavors, playing the drums, and traveling with his wife and four children. Dr. Asrani was recognized by D Magazine as a Best Doctor for 2023, 2024 and 2025. Dr. Asrani is highly rated in 20 conditions, according to our data. His top areas of expertise are Liver Failure, Ascites, Hepatitis, Liver Transplant, and Endoscopy.